Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Medline Inc. announced first quarter 2026 results showing strong net sales growth of 10.7% to $7.4 billion driven by new customer signings and organic growth, while net income declined 25.8% to $239 million due to increased costs and expenses including tariffs and IPO-related employee bonuses. The company raised its full year 2026 organic sales gro…
Applied Materials, Inc. announced that its senior management team will participate in several upcoming investor conferences, including J.P. Morgan, Bernstein, and BofA Securities events. The company will webcast their sessions, providing updates on their materials engineering solutions critical to semiconductor and advanced display industries. The …
Since its Nasdaq listing in early 2026, VenHub Global, Inc. has accelerated growth by expanding its Las Vegas production capacity, advancing autonomous retail technology, securing multiple new Smart Store deployment agreements, and strengthening its payments platform. The company aims to transform high-traffic venues across key sectors by offering …
Bioventus Inc. reported solid financial results for Q1 2026, with revenue increasing 7% to $132.1 million driven by growth across its Pain Treatments, Surgical Solutions, and Restorative Therapies segments. GAAP earnings improved to $0.04 per diluted share from a prior year loss, and non-GAAP earnings nearly doubled to $0.15 per diluted share. The …
BriaCell Therapeutics has received FDA clearance to initiate clinical trials for Bria-BRES+, its next-generation personalized immunotherapy targeting metastatic breast cancer. Building on promising results from the earlier Bria-OTS program, the new therapy aims to enhance immune activation and offer improved efficacy. The company plans to start the…
Cronos Group Inc., a global cannabis company, announced the expanded availability of its Spinach STIX®, a cylindrical-style pre-roll, across multiple Canadian provinces. This expansion targets the rising consumer demand for innovative and portable cannabis pre-roll formats in the Canadian market, which accounts for over a third of national retail c…
Dragonfly Energy Holdings Corp. has been awarded a second round of funding from the Nevada Tech Hub, amounting to $527,000, to expand its in-house cylindrical lithium battery cell prototyping and advanced testing capabilities. This investment aims to accelerate research and development, enhance validation processes, and strengthen integration betwe…
StepStone Group Inc., a global private markets investment firm, announced it will release its financial results for the fourth quarter and fiscal year ended March 31, 2026, on May 20, 2026, followed by a webcast and conference call to discuss the results.
Kura Oncology, a biopharmaceutical company focused on precision cancer medicines, announced its participation in the Bank of America Securities 2026 Healthcare Conference, featuring a fireside chat with company management where they will discuss their pipeline and recent FDA-approved drug KOMZIFTI™ for acute myeloid leukemia.
BridgeBio Pharma announced that the Brazilian regulatory agency ANVISA has approved acoramidis, marketed as Beyonttra, for treatment of transthyretin amyloidosis cardiomyopathy (ATTR-CM). This approval follows positive Phase 3 trial results demonstrating significant reductions in cardiovascular events and hospitalizations, marking the first near-co…
Medicus Pharma Ltd. announced expanded pre-specified data from its Phase 2 SKNJCT-003 study showing a positive, dose-dependent response for its Doxorubicin Microneedle Array (D-MNA) treatment of nodular basal cell carcinoma, strengthening the drug's clinical profile and regulatory positioning ahead of FDA discussions. The 200µg dose cohort showed t…
Cameco (CCJ) is the pure-play uranium supplier best positioned to benefit from an accelerating global buildout of nuclear capacity. With a market cap near $49.9B, a large Western-aligned production base, a near-term string of commercial contracts and partnerships including a meaningful stake in Westinghouse, the stock offers a tradeable asymmetric …
REalloys Inc. has received a memorandum from the Department of War emphasizing the urgent national security need to secure domestic heavy rare earth elements (HREE), particularly Dysprosium and Terbium, ahead of a 2027 ban on Chinese-origin rare earth materials. REalloys is developing the largest heavy rare earth metallization facility outside Chin…
U.S. airline stocks rose sharply after reports that the United States and Iran are close to a one-page memorandum intended to end hostilities and open negotiations on a detailed settlement. The move reduced perceived geopolitical risk, sending Brent crude to a two-week low and lifting major carriers by roughly 5% to 7.6%.
ON Semiconductor Corporation announced a proposed private offering of $1.3 billion aggregate principal amount of Convertible Senior Notes due 2031, with an option for an additional $200 million. The proceeds will be used to pay for convertible note hedge transactions, repurchase up to $400 million of common stock, repay debt, and fund general corpo…
Cal‑Maine (CALM) is the largest U.S. producer of shell eggs and is trading like a cyclical producer at the trough. Recent quarter showed sharply lower sales and earnings as egg prices normalized, but the company's balance sheet, free cash flow and strategic moves (Creighton acquisition, specialty egg mix) argue for a recovery. Valuation is compelli…
X4 Pharmaceuticals announced its Q1 2026 financial results and provided corporate updates highlighting the on-track enrollment completion of its global Phase 3 4WARD trial for mavorixafor in chronic neutropenia by end of Q3 2026. The company also celebrated European Commission approval of XOLREMDI® for WHIM syndrome, marking the first authorized tr…
The New York Times reported net gains in digital-only subscribers that exceeded analyst projections, driven by elevated news consumption amid geopolitical tensions and policy shifts. The company continues to emphasize subscription-led growth and bundled product offerings, and its shares rose in early trading following the announcement.
Sprouts (SFM) looks like a pragmatic long: trading around $79 with a market cap near $7.4B, the stock sits at ~15x forward earnings with healthy free cash flow and a conservative balance sheet. Weak comps and macro sensitivity leave near-term volatility, but management’s buybacks, raised guidance, and store expansion roadmap create a credible path …
Instacart, legally Maplebear, projected second-quarter gross transaction value above consensus and reported stronger-than-expected first-quarter results, driven by both price-sensitive and higher-income shoppers. The company signaled resilience in consumer spending despite macroeconomic uncertainty and emphasized affordability amid potential cost p…
Lifecore Biomedical announced its financial results for Q1 2026, showing a 34% decline in revenue to $23.2 million and a net loss of $15.0 million. Despite top-line challenges, the company implemented cost containment strategies reducing operating expenses by 52%, launched a new ERP system to improve efficiencies, signed three new commercial site t…
TransAlta reported first quarter 2026 results showing strong operational availability and cash flow despite softer Alberta power prices and lower production. The company reaffirmed its 2026 outlook, announced leadership changes, strategic moves in data center development, acquisition of Far North assets, and increased its dividend by 8%. However, a…
Uber Technologies projected second-quarter gross bookings that exceed Wall Street consensus, driven by robust demand in ride-hailing and delivery, expanded international traction and gains from its membership program. Management factored in a roughly 60 basis-point drag from the Middle East conflict while highlighting AI adoption and a push into hi…
Atlas, supported by CoinMarketCap, is assuming responsibility for the price feeds and data delivery services previously run by Binance Oracle across BNB Chain, opBNB and other applicable networks. A 90-day migration window has begun; Atlas offers protocol-level configurability, access to CoinMarketCap’s aggregated pricing from over 905 sources, and…
Royalty Pharma plc reported 10% growth in Portfolio Receipts to $925 million and 13% growth in Royalty Receipts to $887 million in Q1 2026. The company announced up to $1.25 billion in royalty transactions including R&D co-funding deals with Johnson & Johnson and Teva. Positive clinical developments in its portfolio products and strengthened capabi…
